Exploring therapeutic options for Parkinson’s disease: Insights at Master in Drug Discovery and Development seminar series

The College of Pharmacy at Gulf Medical University was pleased to welcome Dr. Rabab Hamed Sayed, Associate Professor of Pharmacology and Toxicology at Cairo University’s Faculty of Pharmacy, as the speaker for a seminar talk on November 20th, 2022.

Dr. Sayed, who has a background in experimental pharmacology and a focus on neuroscience and behavioral pharmacology, presented on the topic of “Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy in a rotenone-induced Parkinson’s disease model in rats.” She discussed the role of these processes in Parkinson’s disease and the potential for modulating them as a therapeutic strategy.

gmu

Dr. Sayed has over 10 years of experience in experimental pharmacology, with a focus on neuroscience and behavioral pharmacology. She has coauthored 27 international publications and has a Scopus H-index of 11. In addition to her research and teaching responsibilities, Dr. Sayed is actively involved in establishing international research projects and partnerships, organizing scientific conferences and workshops, and sharing information with the faculty community about international funding opportunities and collaborative projects.

gmu

The seminar was attended by a large group of faculty members and students in the master in drug discovery and development (MDD) program in the College of Pharmacy, who were eager to learn more about the latest developments in Parkinson’s disease research. Dr. Sayed’s talk provided valuable insights into the potential for modulating histone deacetylase, the ubiquitin proteasome system, and autophagy as a therapeutic approach for this complex disease.